Patents Assigned to Cambrooke Therapeutics, Inc.
  • Patent number: 10124036
    Abstract: Liquid metabolic formulas for dietary management of tyrosinemia, including nutritional formulas and hydration beverages (sport drinks).
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: November 13, 2018
    Assignee: Cambrooke Therapeutics, Inc.
    Inventors: Charles E. Sizer, Kurt Olson, Susan Gingrich
  • Publication number: 20180110241
    Abstract: Described herein are liquid nutritional formulas, such as liquid ketogenic formulas, useful, for example, for management of intractable epilepsy. A ketogenic diet is a high-fat, adequate-protein, low-carbohydrate diet whose consumption shifts metabolism from glycolysis (the metabolism of carbohydrates) and favors ketosis, the metabolism of fatty-acid derived ketone bodies. A ketogenic diet is useful as an alternative therapeutic option for patients with intractable epilepsy and is often the sole source of nutrition, particularly for infants and children.
    Type: Application
    Filed: March 25, 2016
    Publication date: April 26, 2018
    Applicant: Cambrooke therapeutics, Inc.
    Inventors: Kurt Olson, Susan Gingrich
  • Publication number: 20180064784
    Abstract: Liquid metabolic formulas for dietary management of tyrosinemia, including nutritional formulas and hydration beverages (sport drinks).
    Type: Application
    Filed: June 12, 2015
    Publication date: March 8, 2018
    Applicant: Cambrooke Therapeutics, Inc.
    Inventors: Charles E. Sizer, Kurt Olson, Susan Gingrich
  • Publication number: 20170027985
    Abstract: In some aspects, the disclosure relates to compositions useful for the dietary management of inborn errors of metabolism (e.g., PKU, MSUD, HCU, IVA, and MMA/PA). In some embodiments, the disclosure provides a composition comprising a protein source, a fat source, a carbohydrate source, at least one vitamin, and at least one mineral, wherein the protein source comprises at least six free amino acids. In some aspects the disclosure relates to compositions that support bone health.
    Type: Application
    Filed: July 1, 2016
    Publication date: February 2, 2017
    Applicant: Cambrooke Therapeutics, Inc.
    Inventors: Susan Gingrich, Kurt Olson
  • Publication number: 20160366916
    Abstract: Described herein is a nutrition formula, which is a powder that comprises components described herein and can be combined with a liquid, such as water, to produce a milk-like beverage for the dietary management of phenylketonuria (PKU). The powder and resulting beverage have a balanced amino acid profile suitable for dietary management of individuals who have PKU and are lower in calories than powder and milk-like beverages that comprise whey protein, such as cGMP, presently available for use in dietary management of PKU.
    Type: Application
    Filed: June 16, 2016
    Publication date: December 22, 2016
    Applicant: Cambrooke Therapeutics, Inc.
    Inventors: SUSAN GINGRICH, Kurt Olson
  • Publication number: 20160361383
    Abstract: Liquid metabolic formulas for dietary management of tyrosinemia, including nutritional formulas and hydration beverages (sport drinks).
    Type: Application
    Filed: June 12, 2015
    Publication date: December 15, 2016
    Applicant: Cambrooke Therapeutics, Inc.
    Inventors: Charles E. Sizer, Kurt Olson, Susan Gingrich
  • Publication number: 20160316811
    Abstract: This is a process to make a shelf-stable, liquid, ready-to-drink, aseptic nutritional formula for the treatment of PKU, tyrosinemia or other errors of metabolism. The liquid nutritional formula has caseino-glyco-macropeptide as the primary protein source and complementary essential amino acids to complete the requirement profile. The beverage also includes vitamins and minerals sufficient to meet daily requirements. When used as a complete diet, the nutritional formula includes a carbohydrate source and a fat source. The nutritional formula has a pleasant taste.
    Type: Application
    Filed: July 13, 2016
    Publication date: November 3, 2016
    Applicant: Cambrooke Therapeutics, Inc.
    Inventors: Charles E. Sizer, Leah Alea, Kurt Olson
  • Patent number: 9414619
    Abstract: This is a process to make a shelf-stable, liquid, ready-to-drink, aseptic nutritional formula for the treatment of PKU, tyrosinemia or other errors of metabolism. The liquid nutritional formula has caseino-glyco-macropeptide as the primary protein source and complementary essential amino acids to complete the requirement profile. The beverage also includes vitamins and minerals sufficient to meet daily requirements. When used as a complete diet, the nutritional formula includes a carbohydrate source and a fat source. The nutritional formula has a pleasant taste.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: August 16, 2016
    Assignee: Cambrooke Therapeutics, Inc.
    Inventors: Charles E. Sizer, Leah Alea, Kurt Olson